Tuesday, May 05, 2020 3:18:23 PM
According the this majority control was bought...
SunMed Advisors, LLC has recently acquired majority control of CTYX through the purchase of Series A Preferred stock from the two principal holders of CTYX.
So SunMed Advisors, LLC now owns control of CTYX.
Sounds like CTYX is now a public Biotech market firm, or at least a subsidiary of one to me.
SunMed Advisors, LLC has recently acquired majority control of CTYX through the purchase of Series A Preferred stock from the two principal holders of CTYX.
So SunMed Advisors, LLC now owns control of CTYX.
Sounds like CTYX is now a public Biotech market firm, or at least a subsidiary of one to me.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent CUBT News
- Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement • GlobeNewswire Inc. • 05/07/2026 11:00:00 AM
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
